EpiCept (NASDAQ: EPCT) has lost almost 12.5% or $.10 to settle at $.76 with an increased volume of 936,841 shares. Company announced that it has entered into a definitive agreement for the purchase of 8.9 million shares of its common stock at point $.80 per share and five-year warrants to purchase up to an estimated 3.6 million shares of stock at an exercise price of $.75 per share. Company will receive approximately $6.6 million in proceeds from the offering.
EpiCept Corporation is a specialty pharmaceutical company focused on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. Its lead product is Ceplene, which when used concomitantly with low-dose interleukin-2 reduced maintenance therapy in the treatment of acute myeloid leukemia (AML). Its cancer portfolio includes crinobulin, a small molecule vascular disruption agent (VDA), and apoptosis inducer for the treatment of patients with solid tumors. It has completed its first Phase I clinical trial for crinobulin.
Ampal American Israel (NASDAQ: AMPL) has gained 2.69% or six cents to settle at $2.22 a share with a light volume of 10,200 shares. Company announced that it expects that EMGs gas supplied to Israel is expected to resume by February 17, 2011.
Ampal-American Israel Corporation primarily acquires interests in businesses located in the State of Israel or that are Israel-related. The Company's investment focus is principally on companies or ventures where Ampal can exercise significant influence, on its own or with investment partners, and can use its management experience to enhance those investments.
Beazer Homes (NYSE: BZH) has gained .73% or four cents to settle at $5.49 a share with the volume of 2,340,949 shares. Company reported a loss of $.66 per share, which is $.20 worse than the Reuters consensus of $.46 a share. revenues also fell 48.2% year-to-year to settle at $110.3 million versus the $164.3 million consensus.
Beazer Homes USA, Inc. (Beazer) is a diversified homebuilder. The Company designs, sells and builds single-family and multi-family homes. The Company acts as the general contractor for the construction of its home communities.
Warner Music Group (NYSE: WMG) has tumbled 10.75% or $.67 with an increased volume of 500,529 shares traded by midday of Tuesday. Investors sold in panic as the company reported a loss of $.12 per share which was seven cents better than the consensus of $.19; and the revenues fell 14.1% year-to-year to $789 million versus the $798 million consensus. Decline in revenue reflected the transition from physical to digital age in the music industry.
Warner Music Group Corp. is a music content company. The Company consists of two businesses: Recorded Music and Music Publishing. The Recorded Music business produces revenue through the marketing, sale and licensing of recorded music in various physical, such as compact discs (CDs), long playings (LPs), and digital versatile discs (DVDs) and digital (such as downloads and ringtones) formats. The Music Publishing business owns and acquires rights to musical compositions, exploits and markets these compositions and receives royalties or fees for their use.
eDiet.com, Inc. (NASDAQ: DIET) has lost almost 3% of its value or one cent with an increased volume of 207,691 shares, which is three times the average volume of 85,551 shares. Today the company's board of directors have approved a rights offering in which stockholders will receive nontransferable rights to purchase additional shares of the company's common stock, which is par value at $0.001 per share
eDiets.com, Inc. uses technology to bring weight loss solutions to both consumers and businesses. The Company generates revenue in four ways. It sells digital weight-loss programs. It also offers a weight loss oriented meal delivery services. The Company derives licensing revenues for the use of the intellectual property and development revenues related to the planning, design and development of private-label nutrition Websites.
OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. Always do you own homework before investing in any stock.
Forward-Looking Statement: This press release includes
"forward-looking statements" within the meaning of the federal
securities laws, commonly identified by such terms as "believes,"
"looking ahead," "anticipates," "estimates" and
other terms with similar meaning. Although the Company believes that the
assumptions upon which its forward-looking statements are based are reasonable,
it can give no assurance that these assumptions will prove to be correct.
Important factors that could cause actual results to differ materially from the
Company's projections and expectations are disclosed in the Company's filings
with the Securities and Exchange Commission. All forward-looking
statements in this press release are expressly qualified by such cautionary
statements and by reference to the underlying assumptions.
Disclosure: OTCpicks.com has not been compensated for any stocks listed in this stock news report
